{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:39:33Z","timestamp":1775680773406,"version":"3.50.1"},"posted":{"date-parts":[[2021,12,6]]},"group-title":"HIV\/AIDS","reference-count":31,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,12,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>Recommendations for additional doses of COVID vaccine are restricted to people with HIV who have advanced disease or unsuppressed HIV viral load. Understanding SARS-CoV-2 infection risk post-vaccination among PWH is essential for informing vaccination guidelines.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Estimate the risk of breakthrough infections among fully vaccinated people with (PWH) and without (PWoH) HIV in the US.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Design, setting, and participants<\/jats:title>\n                  <jats:p>The Corona-Infectious-Virus Epidemiology Team (CIVET)-II cohort collaboration consists of 4 longitudinal cohorts from integrated health systems and academic health centers. Each cohort identified individuals \u226518 years old, in-care, and fully vaccinated for COVID-19 through 30 June 2021. PWH were matched to PWoH on date fully vaccinated, age group, race\/ethnicity, and sex at birth. Incidence rates per 1,000 person-years and cumulative incidence of breakthrough infections with 95% confidence intervals ([,]) were estimated by HIV status. Cox proportional hazards models estimated adjusted hazard ratios (aHR) of breakthrough infections by HIV status adjusting for demographic factors, prior COVID-19 illness, vaccine type (BNT162b2, [Pfizer], mRNA-1273 [Moderna], Jansen Ad26.COV2.S [J&amp;J]), calendar time, and cohort. Risk factors for breakthroughs among PWH, were also investigated.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Exposure<\/jats:title>\n                  <jats:p>HIV infection<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Outcome<\/jats:title>\n                  <jats:p>COVID-19 breakthrough infections, defined as laboratory evidence of SARS-CoV-2 infection or COVID-19 diagnosis after an individual was fully vaccinated.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 109,599 individuals (31,840 PWH and 77,759 PWoH), the rate of breakthrough infections was higher in PWH versus PWoH: 44 [41, 48] vs. 31 [29, 33] per 1,000 person-years. Cumulative incidence at 210 days after date fully vaccinated was low, albeit higher in PWH versus PWoH overall (2.8% versus 2.1%, log-rank p&lt;0.001, risk difference=0.7% [0.4%, 1.0%]) and within each vaccine type. Breakthrough infection risk was 41% higher in PWH versus PWoH (aHR=1.41 [1.28, 1.56]). Among PWH, younger age (18-24 versus 45-54), history of COVID-19 prior to fully vaccinated date, and J&amp;J vaccination (versus Pfizer) were associated with increased risk of breakthroughs. There was no association of breakthrough with HIV viral load suppression or CD4 count among PWH.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions and Relevance<\/jats:title>\n                  <jats:p>COVID-19 vaccination is effective against infection with SARS-CoV-2 strains circulating through 30 Sept 2021. PWH have an increased risk of breakthrough infections compared to PWoH. Recommendations for additional vaccine doses should be expanded to all PWH.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2021.12.02.21267182","type":"posted-content","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T14:20:22Z","timestamp":1638800422000},"source":"Crossref","is-referenced-by-count":11,"title":["COVID-19 infections post-vaccination by HIV status in the United States"],"prefix":"10.64898","author":[{"given":"Sally B.","family":"Coburn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Humes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raynell","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenna C","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Gebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Napravnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessie K.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay E.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsha","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Horberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia M.","family":"Certa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeena R","family":"Jefferson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Skarbinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A","family":"Leyden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn F.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-6595","authenticated-orcid":false,"given":"Keri N.","family":"Althoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Corona-Infectious-Virus Epidemiology Team (CIVETs) of the NA-ACCORD of IeDEA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2021120805500525000_2021.12.02.21267182v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2034577"},{"key":"2021120805500525000_2021.12.02.21267182v1.2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2035389"},{"key":"2021120805500525000_2021.12.02.21267182v1.3","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2101544"},{"key":"2021120805500525000_2021.12.02.21267182v1.4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7021e3"},{"key":"2021120805500525000_2021.12.02.21267182v1.5","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16634"},{"key":"2021120805500525000_2021.12.02.21267182v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101117"},{"key":"2021120805500525000_2021.12.02.21267182v1.7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2105000"},{"key":"2021120805500525000_2021.12.02.21267182v1.8","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7013e3"},{"key":"2021120805500525000_2021.12.02.21267182v1.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.6564"},{"key":"2021120805500525000_2021.12.02.21267182v1.10","doi-asserted-by":"publisher","DOI":"10.1101\/2021.10.05.21264583"},{"key":"2021120805500525000_2021.12.02.21267182v1.11","doi-asserted-by":"publisher","DOI":"10.1111\/AJT.16713"},{"key":"2021120805500525000_2021.12.02.21267182v1.12","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003902"},{"key":"2021120805500525000_2021.12.02.21267182v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.05.021"},{"key":"2021120805500525000_2021.12.02.21267182v1.14","unstructured":"Centers for Disease Control and Prevention. COVID-19 Vaccines for Moderately to Severely Immunocompromised People | CDC. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/immuno.html. Accessed October 28, 2021."},{"key":"2021120805500525000_2021.12.02.21267182v1.15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042909-093756"},{"key":"2021120805500525000_2021.12.02.21267182v1.16","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyl286"},{"key":"2021120805500525000_2021.12.02.21267182v1.17","unstructured":"When You\u2019ve Been Fully Vaccinated | CDC. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/fully-vaccinated.html. Accessed November 4, 2021."},{"key":"2021120805500525000_2021.12.02.21267182v1.18","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000223670.00890.74"},{"key":"2021120805500525000_2021.12.02.21267182v1.19","unstructured":"Investigative Criteria for Suspected Cases of SARS-CoV-2 Reinfection (ICR) | CDC. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/php\/invest-criteria.html. Accessed November 10, 2021."},{"key":"2021120805500525000_2021.12.02.21267182v1.20","unstructured":"Centers for Disease Control and Prevention. AIDS-Defining Conditions. MMWR Recommendations and Reports. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5710a2.htm. Published December 5, 2008. Accessed November 17, 2021."},{"key":"2021120805500525000_2021.12.02.21267182v1.21","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.ABM0620"},{"key":"2021120805500525000_2021.12.02.21267182v1.22","doi-asserted-by":"publisher","DOI":"10.1002\/WPS.20921"},{"key":"2021120805500525000_2021.12.02.21267182v1.23","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0243523"},{"key":"2021120805500525000_2021.12.02.21267182v1.24","doi-asserted-by":"publisher","DOI":"10.1177\/08982643211002084"},{"key":"2021120805500525000_2021.12.02.21267182v1.25","unstructured":"CDC COVID Data Tracker. CDC COVID-19 Case Line-Level Data, 2019 US Census, HHS Protect. https:\/\/covid.cdc.gov\/covid-data-tracker\/#demographicsovertime. Accessed November 6, 2021."},{"key":"2021120805500525000_2021.12.02.21267182v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(21)00239-3\/ATTACHMENT\/8C85A77E-AEF3-4AD8-A2D0-3CEAE40AEEA7\/MMC1.PDF"},{"key":"2021120805500525000_2021.12.02.21267182v1.27","doi-asserted-by":"publisher","DOI":"10.1001\/JAMANETWORKOPEN.2020.37069"},{"key":"2021120805500525000_2021.12.02.21267182v1.28","doi-asserted-by":"publisher","DOI":"10.1002\/CCR3.3786"},{"key":"2021120805500525000_2021.12.02.21267182v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCV.2020.104577"},{"key":"2021120805500525000_2021.12.02.21267182v1.30","doi-asserted-by":"publisher","DOI":"10.1002\/JMV.26280"},{"key":"2021120805500525000_2021.12.02.21267182v1.31","unstructured":"HIV Medicine Association. COVID-19 Vaccines and People with HIV Frequently Asked Questions. http:\/\/www.hivma.org. http:\/\/www.hivma.org. Accessed November 15, 2021."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2021.12.02.21267182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:31:11Z","timestamp":1768487471000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2021.12.02.21267182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1101\/2021.12.02.21267182","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1001\/jamanetworkopen.2022.15934","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2021,12,6]]},"subtype":"preprint"}}